The ongoing spread of COVID-19 will continue to have major implications for clinical trial operations as we navigate through unchartered territory, and we’re committed to doing our part to support both the research community and the communities where we live and work. As more and more countries take action to manage and mitigate the impact of coronavirus, we know that we must find our way through this devastating global public health crisis together, by collaborating and supporting each other. Our main objective and social responsibility is to protect our staff, ensure business continuity across our global activities and do all we can to help stop the virus from devastating more families and protect those in society most at risk from COVID-19, especially the elderly.
We are in awe of the physicians, nurses, healthcare professionals and countless other essential workers on the front lines of the crisis around the globe, who risk their lives so others may live. Their efforts to fight this pandemic deserve our gratitude, greatest respect and support.
A historic effort in clinical development is underway, and we’re honored to be part of it. Never before have so many of the world’s researchers focused so urgently on a single topic. Within the next couple of weeks and months, the research community should start getting more evidence from large randomized clinical trials, and hopefully the news will be good.
We wish you a happy holiday with all good health and look forward to better times. Please stay safe and take good care of yourselves and your families.